Primary Care Diabetes
Volume 2, Issue 1 , Pages 31-37 , 2008

Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes

  • Saowanee Phumipamorn

      Affiliations

    • Department of Pharmacy, Nue-Klong Community Hospital, Krabi Province 81130, Thailand
    • ,
  • Juraporn Pongwecharak

      Affiliations

    • Department of Clinical Pharmacy, Faculty of Pharmaceutical Science, Prince of Songkla University, Hatyai, Songkhla 90112, Thailand
    • Corresponding Author InformationCorresponding author. Tel.: +66 7 44288873; fax: +66 7 4428222.
    • ,
  • Suchada Soorapan

      Affiliations

    • Department of Clinical Pharmacy, Faculty of Pharmaceutical Science, Prince of Songkla University, Hatyai, Songkhla 90112, Thailand
    • ,
  • Sutthiporn Pattharachayakul

      Affiliations

    • Department of Clinical Pharmacy, Faculty of Pharmaceutical Science, Prince of Songkla University, Hatyai, Songkhla 90112, Thailand

Received 9 July 2007 ,Revised 3 December 2007 ,Accepted 7 December 2007.

References 

  1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053
  2. Shai I, Jiang R, Manson JE, et al. Ethinicty, obesity, and risk of type 2 diabetes in women. Diabetes Care. 2006;29:1585–1590
  3. World Health Organization, Diabetes programme, Facts and figures, www.who.int.diabetes/facts/world_figures/en/print.html (accessed 16 March 2007).
  4. Aekplakorn W, Stolk RP, Neal B, et al. The prevalence and management of diabetes in Thai adults. The international collaborative study of cardiovascular disease in Asia. Diabetes Care. 2003;26:2758–2763
  5. Asia Pacific Cohort Studies Collaboration A. Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions. Asia. Pac. J. Clin. Nutr. 2007;16:187–192
  6. Siripitayakhunkit A. Summary report: surveillance of diabetes, hypertension and ischemic heart diseases. Budget year 2004 (in Thai). Weekly Epidemiol. Surveill. Rep. 2005;36:S29–S34
  7. National Statistics Office, www.nso.go.th (accessed 17 October 2007).
  8. Krabi Provincial Public Health Office, Public Health Statistics, www.kbo.moph.go.th (accessed 17 October 2007).
  9. Onat A, Hergene G, Uyarel H, et al. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu. Kardiol. Derg. 2006;6:314–321(Abstract)
  10. Katulanda P, Sheriff MH, Matthews DR. The diabetes epidemic in Sri Lanka—a growing problem. Ceylon. Med. J. 2006;51:26–28
  11. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Eng. J. Med. 2002;346:393–403
  12. Choe HM, Mitrovich S, Dubay D, et al. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am. J. Manag. Care. 2005;11:253–260
  13. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239
  14. Wongwiwatthananukit S, Krittiyanunt S, Wannapinyo A. Development and validation of an instrument to assess the general knowledge of patients with diabetes (in Thai). Thai J. Pharm. Sci. 2004;28:17–29
  15. American Diabetes Association . Standard of medical care in diabetes. Diabetes Care. 2005;28(Suppl. 1):S4–S36
  16. Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am. J. Med. 2005;118:276–284
  17. Clifford RM, Davis WA, Batty KT, et al. Effect of pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771–776
  18. Jaber LA, Halapy H, Fernet M, et al. Evaluation of a pharmaceutical care model on diabetes management. Ann. Pharmacother. 1996;30:238–243
  19. Sardakis A, Rosenqvist U. Experience-based group education in type 2 diabetes a randomized controlled trial. Pat. Educ. Couns. 2004;53:291–298
  20. Scott DM, Boyd ST, Stephan M, et al. Outcomes of pharmacist-managed diabetes care services in a community health center. Am. J. Health-Syst. Pharm. 2006;63:2116–2122
  21. Odegard PS, Goo A, Hummel J, et al. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann. Pharmacother. 2005;39:433–440
  22. C.M. Renders, G.D. Valk, S. Griffin, et al., Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings, Cochrane Database of Systematic Reviews 2001, Issue 4, Art. No.: CD001481, doi:10.1002/14651858, CD001481.
  23. Ko GTC, Li JKY, Kan ECY, Lo MKW. Effects of a structured health education programme by a diabetic education nurse on cardiovascular risk factors in Chinese Type 2 diabetic patients: a 1-year prospective randomized study. Diabet. Med. 2004;21:1274–1279
  24. van de Sande M, Dippenaar H, Rutten GEHM. The relationship between patient education and glycaemic control in a South African township. Primary Care Diabetes. 2007;1:87–91
  25. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am. J. Med. Qual. 2000;15:137–142
  26. Bogden PE, Koonts LM, Williamson P, et al. The physician and pharmacist team. An approach to cholesterol reduction. J. Gen. Intern. Med. 1997;12:158–164
  27. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20:1508–1516
  28. Peterson GM, Fitzmaurice KD, Naunton M, et al. Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. J. Clin. Pharm. Ther. 2004;29:23–33
  29. Simpson SH, Johnson JA, Biggs RS, et al. SCRIP investigators: greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Pharmacotherapy. 2004;(24):389–394
  30. Lindenmeyer A, Hearnshaw H, Vermeire E, et al. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J. Clin. Pharm. Ther. 2006;31:409–419
  31. Suppapitiporn S, Chindavijak B, Onsanit S. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycaemic control of type 2 diabetes mellitus: a randomized controlled trial. J. Med. Assoc. Thai. 2005;88(Suppl. 4):S134–S141
  32. J. Beney, L.A. Bero, C. Bond, Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcome, Cochrane Database of Systematic Reviews 2000, Issue 2, Art. No.: CD000336, doi:10.1002/14651858, CD000336.
  33. Vermeire E, Wens J, Van Royen P, et al., Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus, Cochrane Database of Systematic Reviews 2005, Issue 2, Art. No.: CD003638, doi:10.1002/14651858, CD003638.pub2.
  34. R.B. Haynes, X. Yao, A. Degani, S. Kripalani, A. Garg, H.P. McDonald, Interventions for enhancing medication adherence, Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD000011. doi:10.1002/14651858, CD000011.pub2.
  35. Bradshaw C, Bryce C, McColl E, Eccles M, Sampson R. Can we improve the education for type 2 diabetes patients in general practice? A pilot study of the effects of differing educational delivery methods. Pract. Diab. Int. 1999;(16):241–245

☆ Part of this study was accepted as a poster presentation at the 3rd World Congress of the Board of Pharmaceutical Sciences of FIP (PSWC 2007) in Amsterdam, The Netherlands during 22–25 April 2007.

PII: S1751-9918(07)00180-5

doi: 10.1016/j.pcd.2007.12.001

Primary Care Diabetes
Volume 2, Issue 1 , Pages 31-37 , 2008

Article Tools

* Image Usage & Resolution